| Schedule of Share-based Compensation, Stock Options, Activity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-Average
|
|
|
|
|
|
|
|
|
|
|
|
Remaining
|
|
Aggregate
|
|
|
|
Number of
|
|
Weighted-Average
|
|
Contractual Term (In
|
|
Intrinsic
|
|
|
|
Options
|
|
Exercise Price
|
|
Years)
|
|
Value
|
|
Outstanding at December 31, 2019
|
|
4,197,000
|
|
$
|
2.13
|
|
6.70
|
|
$
|
255,000
|
|
Grants
|
|
—
|
|
$
|
—
|
|
|
|
|
|
|
Exercised
|
|
—
|
|
$
|
—
|
|
|
|
|
|
|
Forfeited/cancelled/expired/settled
|
|
24,000
|
|
$
|
3.17
|
|
|
|
|
|
|
Balance as of March 31, 2020
|
|
4,173,000
|
|
$
|
2.12
|
|
6.49
|
|
$
|
14,458
|
|
Vested and expected to vest at March 31, 2020
|
|
4,170,000
|
|
$
|
2.12
|
|
6.49
|
|
$
|
—
|
|
Unvested at March 31, 2020
|
|
17,000
|
|
$
|
1.90
|
|
7.46
|
|
$
|
—
|
|
Exercisable at March 31, 2020
|
|
4,156,000
|
|
$
|
2.12
|
|
6.48
|
|
$
|
14,458
|
|
| Schedule of Share-based Compensation, Restricted Stock Units Award Activity |
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
|
|
|
Fair Value
|
|
|
|
|
|
at Grant
|
|
|
|
Shares
|
|
Date
|
|
Unvested at December 31, 2019
|
|
1,814,000
|
|
$
|
2.14
|
|
Grants
|
|
—
|
|
$
|
—
|
|
Vested
|
|
(1,630,000)
|
|
$
|
2.14
|
|
Forfeited/cancelled/expired
|
|
—
|
|
$
|
—
|
|
Unvested at March 31, 2020
|
|
184,000
|
|
$
|
2.10
|
|